These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis. Jawien J Curr Pharm Biotechnol; 2012 Oct; 13(13):2435-9. PubMed ID: 22280417 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605 [TBL] [Abstract][Full Text] [Related]
4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W J Pathol; 2001 Sep; 195(2):257-63. PubMed ID: 11592107 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Chi H; Messas E; Levine RA; Graves DT; Amar S Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494 [TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Meir KS; Leitersdorf E Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1006-14. PubMed ID: 15087308 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241 [TBL] [Abstract][Full Text] [Related]
9. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice. Desai A; Zhao Y; Warren JS Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814 [TBL] [Abstract][Full Text] [Related]
10. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Tian J; Pei H; James JC; Li Y; Matsumoto AH; Helm GA; Shi W Biochem Biophys Res Commun; 2005 Apr; 329(3):1102-7. PubMed ID: 15752767 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Raffai RL; Loeb SM; Weisgraber KH Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220 [TBL] [Abstract][Full Text] [Related]
12. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-). Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565 [TBL] [Abstract][Full Text] [Related]
13. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Zhang S; Picard MH; Vasile E; Zhu Y; Raffai RL; Weisgraber KH; Krieger M Circulation; 2005 Jun; 111(25):3457-64. PubMed ID: 15967843 [TBL] [Abstract][Full Text] [Related]
14. Effect of natural killer T cell activation on the initiation of atherosclerosis. van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872 [TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. Olszanecki R; Jawień J; Gajda M; Mateuszuk L; Gebska A; Korabiowska M; Chłopicki S; Korbut R J Physiol Pharmacol; 2005 Dec; 56(4):627-35. PubMed ID: 16391419 [TBL] [Abstract][Full Text] [Related]
17. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753 [TBL] [Abstract][Full Text] [Related]
18. Effects of insulin sensitizers on plaque vulnerability associated with elevated lipid content in atheroma in ApoE-knockout mice. Cefalu WT; Wang ZQ; Schneider DJ; Absher PM; Baldor LC; Taatjes DJ; Sobel BE Acta Diabetol; 2004 Mar; 41(1):25-31. PubMed ID: 15057551 [TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin T content in heart and skeletal muscle and in blood samples from ApoE/LDL receptor double knockout mice. Löwbeer C; Forsberg AM; Tokuno S; Hemdahl AL; Gustafsson SA; Valen G Clin Chim Acta; 2004 Jun; 344(1-2):73-8. PubMed ID: 15149873 [TBL] [Abstract][Full Text] [Related]
20. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice. Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]